| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680421 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2016 | 12 Pages |
Abstract
Detailed evaluation of SCD could provide accessible indication of the presence of β-amyloid or cognitive deficits, which might prove useful for early diagnosis and clinical trial enrichment strategies.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Renaud La Joie, Audrey Perrotin, Stéphanie Egret, Florence Pasquier, Clémence Tomadesso, Florence Mézenge, Béatrice Desgranges, Vincent de La Sayette, Gaël Chételat,